Seamless, Expedited Transition of Global Pharmacovigilance Services for Six Oncology Products

Download our latest pharmacovigilance (PV) case study on the migration of comprehensive PV services for six oncology products in the U.S. and Europe. Discover how UBC’s strategic approach helped our pharmaceutical sponsor easily maneuver through complex PV challenges, as our leading team of experts:

  • Transferred comprehensive PV services for over 11,000 cases

      
  • Expedited global reporting
  • Handled complex data migration from over 12 sources
  • Managed natural disaster impact on database transfer
  • Tracked activities against a comprehensive transition plan and checklist
  • Exceeded aggressive overall program deadlines

Complete the form to the right to read the full case study and learn more about our impactful result.

UBC is a leader in pharmacovigilance, combining deep therapeutic experience with customized PV solutions and innovative, automated technology to help you stay in control of your patient safety and regulatory responsibilities.

For more information on UBC’s pharmacovigilance services, visit here.

Thank You for Connecting with UBC

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

What You Can Expect Next

Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.

Get Ready to Change Your Business

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

Service Request

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.